Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Nasal high-flow therapy for type II respiratory failure in COPD: A report of four cases.

Pavlov I, Plamondon P, Delisle S.

Respir Med Case Rep. 2017 Jan 1;20:87-88. doi: 10.1016/j.rmcr.2016.12.006. eCollection 2017.

2.

GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.

Roberts JL, Tavallai M, Nourbakhsh A, Fidanza A, Cruz-Luna T, Smith E, Siembida P, Plamondon P, Cycon KA, Doern CD, Booth L, Dent P.

J Cell Physiol. 2015 Oct;230(10):2552-78. doi: 10.1002/jcp.25014.

3.

Assessment of the contribution of electron microscopy to nanoparticle characterization sampled with two cascade impactors.

Noël A, L'Espérance G, Cloutier Y, Plamondon P, Boucher J, Philippe S, Dion C, Truchon G, Zayed J.

J Occup Environ Hyg. 2013;10(3):155-72. doi: 10.1080/15459624.2012.760391.

PMID:
23356435
4.

Immunological responses in C3H/HeJ mice following nose-only inhalation exposure to different sizes of beryllium metal particles.

Salehi F, Zayed J, Audusseau S, Muller C, Truchon G, Plamondon P, L'espérance G, Chevalier G, Mazer B.

J Appl Toxicol. 2009 Jan;29(1):61-8. doi: 10.1002/jat.1383.

PMID:
18980269
5.

Characterization of beryllium particles from CAlSiFrit.

Muller C, L'Esperance G, Plamondon P, Kennedy G, Zayed J.

J Toxicol Environ Health A. 2008;71(16):1091-9. doi: 10.1080/15287390802114493.

PMID:
18569621
6.

Identification of a novel two-partner secretion locus in Moraxella catarrhalis.

Plamondon P, Luke NR, Campagnari AA.

Infect Immun. 2007 Jun;75(6):2929-36. Epub 2007 Apr 9.

7.

Physical and chemical characterization of beryllium particles from several workplaces in Québec, Canada--part B: time-of-flight secondary-ion mass spectroscopy.

Rouleau M, Dion C, Plamondon P, L'Espérance G, Zayed J.

J Toxicol Environ Health A. 2005 Nov 12;68(21):1907-16.

PMID:
16207637
8.

Physical and chemical characterization of beryllium particles from several workplaces in Québec, Canada--part A: determining methods for the analysis of low levels of beryllium.

Rouleau M, Dion C, Plamondon P, Kennedy G, L'Espérance G, Zayed J.

J Toxicol Environ Health A. 2005 Nov 12;68(21):1889-905.

PMID:
16207636
9.

Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells.

Shen F, Ruddy MJ, Plamondon P, Gaffen SL.

J Leukoc Biol. 2005 Mar;77(3):388-99. Epub 2004 Dec 10.

PMID:
15591425
11.

Physical and chemical characterization of mn phosphate/sulfate mixture used in an inhalation toxicology study.

Beaupré LA, Salehi F, Zayed J, Plamondon P, L'Espérance G.

Inhal Toxicol. 2004 Apr;16(4):231-44.

PMID:
15204770
12.

Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.

Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, Nakayama K, Mayrand D.

Infect Immun. 2003 Aug;71(8):4742-8.

13.

The collagenase activity of Porphyromonas gingivalis is due to Arg-gingipain.

Houle MA, Grenier D, Plamondon P, Nakayama K.

FEMS Microbiol Lett. 2003 Apr 25;221(2):181-5.

14.

Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.

Grenier D, Plamondon P, Sorsa T, Lee HM, McNamara T, Ramamurthy NS, Golub LM, Teronen O, Mayrand D.

J Periodontol. 2002 Jan;73(1):79-85.

PMID:
11846203
15.

Effects of dipeptide bestatin on Porphyromonas gingivalis and epithelial cells.

Labbé S, Grenier D, Plamondon P, Uitto VJ, Mayrand D.

J Periodontol. 2001 Jun;72(6):714-21.

PMID:
11453232
16.

Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Grenier D, Imbeault S, Plamondon P, Grenier G, Nakayama K, Mayrand D.

Infect Immun. 2001 Aug;69(8):5166-72.

17.

Studies on the aminopeptidase activities of Porphyromonas gingivalis.

Grenier D, Gauthier P, Plamondon P, Nakayama K, Mayrand D.

Oral Microbiol Immunol. 2001 Aug;16(4):212-7.

PMID:
11442845
18.

Phenotypic consequences resulting from a methionine-to-valine substitution at position 48 in the HPr protein of Streptococcus salivarius.

Plamondon P, Brochu D, Thomas S, Fradette J, Gauthier L, Vaillancourt K, Buckley N, Frenette M, Vadeboncoeur C.

J Bacteriol. 1999 Nov;181(22):6914-21.

Supplemental Content

Loading ...
Support Center